JAKMIP2 Activators
The functional activity of JAKMIP2 is intricately connected to the dynamic equilibrium of microtubule assembly and disassembly. Specific chemical activators can influence this equilibrium by modulating the cellular signaling pathways and phosphorylation status that JAKMIP2 is a part of. For instance, compounds that augment intracellular cAMP levels lead to the activation of kinases, such as protein kinase A, which in turn may phosphorylate substrates that stabilize microtubules, enhancing JAKMIP2's engagement with the microtubule network. Similarly, activators that increase intracellular calcium concentrations can activate calcium/calmodulin-dependent kinases, which may alter the phosphorylation state of proteins associated with microtubule dynamics, potentially promoting the role of JAKMIP2 in this context. Moreover, the inhibition of protein phosphatases by certain chemicals ensures a heightened phosphorylation environment within cells, which could contribute to the maintenance of microtubule integrity and indirectly increase the activity of JAKMIP2 associated with these structures.
On the other hand, agents that directly interact with tubulin can also have an indirect impacton the role of JAKMIP2. For example, microtubule-targeting agents that either destabilize or stabilize microtubules can create a cellular response that compensates for these effects, leading to enhanced microtubule dynamics and potentially more pronounced involvement of JAKMIP2 in stabilizing these critical cytoskeletal components. Some compounds bind to tubulin, preventing its polymerization; this perturbation might elicit a cellular response that favors microtubule assembly and stability, thereby increasing JAKMIP2's activity in microtubule binding and regulation. Conversely, other substances stabilize microtubules by binding to β-tubulin, which can paradoxically result in a cellular environment that favors JAKMIP2's role in microtubule interaction and maintenance. Additionally, the modulation of kinase activity through the inhibition of glycogen synthase kinase-3 (GSK-3) can lead to a change in the phosphorylation landscape of microtubule-associated proteins, further influencing JAKMIP2's activity in microtubule dynamics.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which may phosphorylate proteins involved in microtubule assembly or stabilization, thus potentially enhancing the microtubule-interacting functions of JAKMIP2. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
As a cAMP analog, 8-Bromo-cAMP elevates cAMP levels to activate protein kinase A (PKA), which might phosphorylate substrates involved in microtubule dynamics, potentially increasing JAKMIP2 activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentration, influencing pathways that could affect microtubule stability and, by extension, JAKMIP2's interaction with them. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog that mimics the effect of cAMP in the cell, possibly contributing to an environment that promotes JAKMIP2's role in microtubule regulation. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as a calcium ionophore to raise intracellular calcium levels, which may modify the activity of calcium/calmodulin-dependent kinase and thus potentially increase JAKMIP2's activity concerning microtubule interactions. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits protein phosphatases 1 and 2A, potentially leading to increased phosphorylation status of proteins associated with microtubule dynamics, indirectly enhancing JAKMIP2's function. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases, leading to increased phosphorylation within the cell that might indirectly augment JAKMIP2's role in microtubule interaction and stabilization. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Vinblastine binds to tubulin, inhibiting microtubule formation, which may shift the equilibrium toward microtubule assembly and stabilization, potentially increasing JAKMIP2's functional activity in microtubule binding. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Stabilizes microtubules by binding to β-tubulin, enhancing microtubule polymerization, which may indirectly promote JAKMIP2's interaction and stabilization of microtubules. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubule polymerization, which may lead to compensatory mechanisms that stabilize microtubules, potentially enhancing the activity of JAKMIP2 in microtubule dynamics. | ||||||